Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 9 von 2244

Details

Autor(en) / Beteiligte
Titel
A Novel Approach to Increase Human Islet Cell Mass While Preserving β-Cell Function
Ist Teil von
  • Diabetes (New York, N.Y.), 2002-12, Vol.51 (12), p.3435-3439
Ort / Verlag
Alexandria, VA: American Diabetes Association
Erscheinungsjahr
2002
Quelle
MEDLINE
Beschreibungen/Notizen
  • A Novel Approach to Increase Human Islet Cell Mass While Preserving β-Cell Function Gillian M. Beattie 1 , Anthony M.P. Montgomery 1 , Ana D. Lopez 1 , Ergeng Hao 1 , Brandon Perez 1 , Margaret L. Just 1 , Jonathan R.T. Lakey 2 , Marquis E. Hart 1 and Alberto Hayek 1 1 Department of Pediatrics and Surgery, The Whittier Institute, University of California at San Diego, La Jolla, California 2 Surgical Medical Research Institute, University of Alberta, Edmonton, Alberta, Canada Abstract Human islet expansion in monolayer culture leads to loss of function and senescence. By maintaining the 3-D configuration of islets in fibrin gels, it is feasible to expand β-cells in response to hepatocyte growth factor (HGF) while preserving physiologic glucose responsiveness both in vitro and in vivo after transplantation into nude mice. Islets were cultured free floating with or without growth factors and nicotinamide and in fibrin gels with the same conditions. Proliferation was observed only in islets cultured in fibrin gels and the cocktail; total insulin increased by threefold, with a concomitant increase in β-cell mass by morphometry. Insulin release after glucose challenge was also preserved. Islets in fibrin gels gave rise in vivo to large grafts rich in insulin and glucagon, and grafts from free-floating islets were smaller with fewer endocrine cells. Circulating human C-peptide levels were higher than in the mice receiving free-floating islets. In summary, fibrin allows for HGF-mediated cell proliferation while preserving glucose responsiveness in an environment that preserves cell-cell contacts. Limited islet ex vivo expansion under these conditions may improve recipient-donor tissue ratios to equal the functional results of whole-organ transplants. Footnotes Address correspondence and reprint requests to A. Hayek, MD, The Whittier Institute-UCSD Department of Pediatrics, 9894 Genesee Ave., La Jolla, CA 92037. E-mail: ahayek{at}ucsd.edu . Received for publication 26 June 2002 and accepted in revised form 19 August 2002. HGF, hepatocyte growth factor; SF, scatter factor. DIABETES

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX